Global IV Tube Market Insights and Forecast to 2028

IV Tube is intended to deliver fluids including nutrients and medications into a patient’s body in controlled amounts. The increased patient base in different regions comprising patients affected with diabetes and chronic pain is anticipated to drive the growth of the global IV Tube and accessories market. The APAC region offers strong growth potential for IV Tube and accessories on account of the increasing manufacturing base .
Market Analysis and Insights: Global IV Tube Market
Due to the COVID-19 pandemic, the global IV Tube market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Pediatric accounting for % of the IV Tube global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China IV Tube market size is valued at US$ million in 2021, while the US and Europe IV Tube are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe IV Tube landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of IV Tube include Baxter International, Hospira, Becton Dickinson, B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical, ICU Medical, Zyno Medical and Nipro Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global IV Tube Scope and Segment
IV Tube market is segmented by Type and by Application. Players, stakeholders, and other participants in the global IV Tube market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Pediatric
Adult
Geriatric
Segment by Application
Hospitals
Specialized Clinics
Ambulatory Surgical Centers
Skilled Nursing Facilities
Long Term Care Centers
Others
By Company
Baxter International
Hospira
Becton Dickinson
B. Braun Melsungen AG
Fresenius Kabi AG
Smiths Medical
ICU Medical
Zyno Medical
Nipro Corporation
Vygon U.S.A
Health Line International Corporation
Bicakcilar
Bionic Medizintechnik
Rontis
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E